So, the UK government is considering reclassing ketamine as a Class A drug. The Home Office asked the Advisory Council on the Misuse of Drugs to “carefully consider” the issue. Do you think ketamine should count as a Class A drug? Vote on our poll to tell us how how feel about this issue.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.

Heaps of ketamine, MDMA and illegal weed were seized by authorities as they busted a drug lab in Queens and arrested the ringleader of the dangerous narcotics operation, prosecutors said Friday.

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year than those who reported no past-year drug use.

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral antidepressants. On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray,

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

Celebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what they've said

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term complications.

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental health conditions. However, they may cover the FDA-approved nasal spray, Spravato, which contains a derivative of ketamine called esketamine.

The Lamb of God frontman called the tech billionaire a "complete asshole." Randy Blythe Rips Elon Musk: He’s President Trump’s “Ketamine-Fueled Pet Rocket Monkey”

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.